Every earnings call for FAIRCHEMOR — management tone, guidance, KPIs and promise tracking, quarter by quarter.
FAIRCHEMOR · 6 transcripts · Chemicals · latest Q4 FY26Revenue ₹117 cr (−3% YoY); EBITDA ₹8 cr; EBITDA Margin 6.9%. Q4 FY26 EBITDA margin improved to 6.9% from 3.64% in Q4 FY25, driven by better price realization and moderated import pressure.
Read full transcript & analysisRevenue ₹100 cr (−12% YoY); EBITDA ₹4 cr; EBITDA Margin 4.2%. Q3 FY26 Revenue from operations stood at ₹100 crores, reflecting a 12% year-on-year decline.
Read full transcript & analysisRevenue (Q2 FY26) ₹112 cr (−20% YoY); EBITDA (Q2 FY26) ₹4 cr (−52% YoY); EBITDA Margin (Q2 FY26) 3.77%. Q2 FY26 Revenue from operations stood at INR 112 crores, a 20% decline YoY.
Read full transcript & analysisRevenue from Operations ₹131 cr (−21% YoY); EBITDA ₹5 cr; EBITDA Margin 3.97%. Revenue from operations increased by 8.5% quarter-on-quarter to INR 131 crores.
Read full transcript & analysisRevenue from Operations (Q4) ₹121 cr (−25% YoY); EBITDA (Q4) ₹4 cr; EBITDA Margin (Q4) 3.64%. Q4 volumes increased by over 11% QoQ.
Read full transcript & analysisRevenue from Operations ₹114 cr (−23% YoY); EBITDA ₹8 cr (−61% YoY); Net Profit ₹4 cr. Q3 FY25 revenue from operations declined 23% YoY to Rs. 114 crores.
Read full transcript & analysis